Tg Therapeutics (TGTX) Acquisitions (2011)
Tg Therapeutics (TGTX) posted quarterly Acquisitions of $10386.0 for Q4 2011.
Tg Therapeutics (TGTX) Acquisitions (2011) Analysis & Trends
Tg Therapeutics' Acquisitions history runs 1 years deep, the most recent figure standing at $10386.0 for Q4 2011.
- In Q4 2011, Acquisitions changed N/A year-over-year to $10386.0; the TTM figure through Sep 2012 stood at $10386.0 (changed N/A YoY), while the FY2012 annual figure was $10386.0, changed N/A from the prior year.
- Acquisitions for Q4 2011 stood at $10386.0.
- The five-year high for Acquisitions was $10386.0 in Q4 2011, with the low at $10386.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 10,386.00 |